Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer
about
The emerging role of neoadjuvant chemotherapy for rectal cancerThe role of capecitabine in locally advanced rectal cancer treatment: an update.Prognosis of rectal cancer patients improves with downstaging by intensified neoadjuvant radiochemotherapy - a matched pair analysis.Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trialNeoadjuvant treatment in rectal cancer: actual status.A phase II study of oxaliplatin with 5-FU/folinic acid and concomitant radiotherapy as a preoperative treatment in patients with locally advanced rectal cancerEarly increase in circulating carbonic anhydrase IX during neoadjuvant treatment predicts favourable outcome in locally advanced rectal cancer.Current status of intensified neo-adjuvant systemic therapy in locally advanced rectal cancer.Successful treatment of anal gland adenocarcinoma with combined modality therapy.Mortality risk after preoperative versus postoperative chemotherapy and radiotherapy in lymph node-positive rectal cancer.Clinical factors of post-chemoradiotherapy as valuable indicators for pathological complete response in locally advanced rectal cancerMultidisciplinary treatment of resectable rectal cancer.Cetuximab and chemoradiation for rectal cancer--is the water getting muddy?Induction chemotherapy before chemoradiotherapy and surgery for locally advanced rectal cancer : is it time for a randomized phase III trial?A complete response to mFOLFOX6 and panitumumab chemotherapy in advanced stage rectal adenocarcinoma: a case reportTotal neoadjuvant therapy for rectal cancer: An emerging option.Accomplishments in 2008 in the adjuvant treatment of rectal cancerPhase II study of pre-operative radiotherapy with capecitabine and oxaliplatin for rectal cancer and carcinoembryonic antigen as a predictor of pathological tumour response.Addition of oxaliplatin to capecitabine-based preoperative chemoradiotherapy for locally advanced rectal cancer: Long-term outcome of a phase II study.Prospective phase II trial of neoadjuvant chemo-radiotherapy with Oxaliplatin and Capecitabine in locally advanced rectal cancer (XELOXART).Clinical outcome of neoadjuvant chemoradiation therapy with oxaliplatin and capecitabine or 5-fluorouracil for locally advanced rectal cancer.Phase II study of preoperative radiotherapy and concomitant weekly intravenous oxaliplatin combined with oral capecitabine for stages II-III rectal cancer.Contemporary management of locally advanced rectal cancer: Resolving issues, controversies and shifting paradigms.Induction FOLFOX followed by preoperative hyperfractionated radiotherapy plus bolus 5-fluorouracil in locally advanced rectal carcinoma: single arm phase I-II study.Simultaneous neoadjuvant radiochemotherapy with capecitabine and oxaliplatin for locally advanced rectal cancer. Treatment outcome outside clinical trials.Systemic immune response induced by oxaliplatin-based neoadjuvant therapy favours survival without metastatic progression in high-risk rectal cancer.Prospective clinical study of capecitabine plus oxaliplatin concurrent chemoradiotherapy after radical resection of rectal cancer
P2860
Q34234935-698FA11A-986E-4AA8-B74A-710AE993A01DQ34276823-4307D062-9691-4A56-ACF9-90937CA2262CQ34943505-30034107-CDC3-4004-8055-170DB8BD256EQ35046474-044FA7CE-9A85-4FC8-B358-7C55A986AA34Q35687452-869F460F-93DC-4DAE-94F7-5D4C91492ACCQ35691981-031C8523-70FA-4948-A20A-F308C37CE529Q35709494-E8A6F69D-DE14-4BF7-8C97-A3B338560AD9Q35987944-E1993894-5C46-444D-9306-B55A687C3661Q36014974-6E056A9D-61A3-41C2-A0F7-A5804C7EF4D0Q36551503-4F8A9672-9FCB-41B9-8879-9BE72A3C4A76Q37156190-0D580DDF-8763-4DC8-9877-FD819F2BCED8Q37578503-0EBBAB57-6ED2-4679-8DB8-FC7682CD57BAQ37697800-D917D64C-4B7E-422F-B7CF-3CE52A668A58Q37817000-AB472DA2-CDF8-4D6A-8D01-CF8B7B958A38Q38760219-EE20B5CC-551A-4E26-84DD-8275D8A57EC1Q39179402-A323298B-888D-4038-AB95-40E8D9C6F06AQ42002475-314A1AFF-DEA1-41B3-BE3B-2D8F0E8E2C11Q43048706-10EE1550-B63E-467B-BB2D-CC579A068816Q43623679-F2A55549-4E27-4040-9922-97CA324AC6AFQ44197593-0FA6F632-5738-42ED-9959-9D86E4540576Q44483887-21EA1695-E24A-4069-9EDD-9CC5627D2120Q51320998-C77A286F-40F2-42C6-9C14-5479E53D6A90Q52653160-37E6BAB7-BFEF-4E19-88BB-C83386CA5B5DQ53590916-CB0B3B08-9C31-4DDA-9308-1ECD37429B72Q53724796-4CAAAC9E-A617-4069-9D04-E2D55D498047Q54114270-3EFDB070-83B3-4D4B-A554-DF87B17AD57EQ58696703-223943AE-7917-4A02-98F2-BE4910A4E3AF
P2860
Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Phase II study of capecitabine ...... locally advanced rectal cancer
@ast
Phase II study of capecitabine ...... locally advanced rectal cancer
@en
type
label
Phase II study of capecitabine ...... locally advanced rectal cancer
@ast
Phase II study of capecitabine ...... locally advanced rectal cancer
@en
prefLabel
Phase II study of capecitabine ...... locally advanced rectal cancer
@ast
Phase II study of capecitabine ...... locally advanced rectal cancer
@en
P2093
P2860
P356
P1476
Phase II study of capecitabine ...... locally advanced rectal cancer
@en
P2093
D Koeberle
F Heitzmann
J Neuweiler
L Terraciano
R Burkhard
R Winterhalder
R von Moos
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604297
P407
P577
2008-03-18T00:00:00Z
P5875
P6179
1005504268